SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-154237
Filing Date
2015-04-29
Accepted
2015-04-29 06:09:36
Documents
4
Period of Report
2015-04-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d917460d8k.htm 8-K 14035
2 EX-99.1 d917460dex991.htm EX-99.1 10454
3 GRAPHIC g917460img1.jpg GRAPHIC 7716
4 GRAPHIC g917460img2.jpg GRAPHIC 6194
  Complete submission text file 0001193125-15-154237.txt   45395
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 15809945
SIC: 2834 Pharmaceutical Preparations